These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3107448)

  • 1. Glyburide-induced hepatitis.
    Goodman RC; Dean PJ; Radparvar A; Kitabchi AE
    Ann Intern Med; 1987 Jun; 106(6):837-9. PubMed ID: 3107448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulomatous hepatitis associated with glyburide.
    Saw D; Pitman E; Maung M; Savasatit P; Wasserman D; Yeung CK
    Dig Dis Sci; 1996 Feb; 41(2):322-5. PubMed ID: 8601376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestatic liver injury after glimepiride therapy.
    Chounta A; Zouridakis S; Ellinas C; Tsiodras S; Zoumpouli C; Kopanakis S; Giamarellou H
    J Hepatol; 2005 Jun; 42(6):944-6. PubMed ID: 15885370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.
    van Basten JP; van Hoek B; Zeijen R; Stockbrügger R
    Neth J Med; 1992 Jun; 40(5-6):305-7. PubMed ID: 1436270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliclazide-induced acute hepatitis.
    Dourakis SP; Tzemanakis E; Sinani C; Kafiri G; Hadziyannis SJ
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):119-21. PubMed ID: 10656221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glibenclamide and liver disease.
    Petrogiannopoulos C; Zacharof A
    Diabetes Care; 1997 Jul; 20(7):1215. PubMed ID: 9203475
    [No Abstract]   [Full Text] [Related]  

  • 7. Glyburide-induced hepatitis.
    Meadow P; Tullio CJ
    Clin Pharm; 1989 Jul; 8(7):470. PubMed ID: 2502355
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholestatic hepatitis caused by glybenclamide in a patient with hepatitis C virus].
    Pérez-Roldán F; Aguirre A; Bañares R; Casado M; González-Asanza C; Alvarez E; Clemente G
    Rev Esp Enferm Dig; 1995 Feb; 87(2):174-6. PubMed ID: 7748712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suloctidil-induced hepatotoxicity.
    Chung MW; Komorowski RA; Varma RR
    Gastroenterology; 1988 Aug; 95(2):490-1. PubMed ID: 2839389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine hepatotoxicity.
    Fich A; Schwartz J; Braverman D; Zifroni A; Rachmilewitz D
    Am J Gastroenterol; 1984 May; 79(5):401-2. PubMed ID: 6144268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorpropamide hepatotoxicity: report of a case and review of the literature.
    Schneider HL; Hornbach KD; Kniaz JL; Efrusy ME
    Am J Gastroenterol; 1984 Sep; 79(9):721-4. PubMed ID: 6475904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus.
    Seaman WE; Ishak KG; Plotz PH
    Ann Intern Med; 1974 Jan; 80(1):1-8. PubMed ID: 4810348
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenytoin-induced chronic hepatitis.
    Roy AK; Mahoney HC; Levine RA
    Dig Dis Sci; 1993 Apr; 38(4):740-3. PubMed ID: 8462373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of drug-induced hepatitis].
    Polunina TE
    Ter Arkh; 1988; 60(2):119-21. PubMed ID: 3368853
    [No Abstract]   [Full Text] [Related]  

  • 16. The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.
    Tuccori M; Wu JW; Yin H; Majdan A; Azoulay L
    Diabetes Care; 2015 Nov; 38(11):2083-9. PubMed ID: 26341130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study.
    Abdelmoneim AS; Eurich DT; Gamble JM; Johnson JA; Seubert JM; Qiu W; Simpson SH
    Diabetes Obes Metab; 2014 Jan; 16(1):22-9. PubMed ID: 23802997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspected ciprofloxacin-induced hepatotoxicity.
    Villeneuve JP; Davies C; Côté J
    Ann Pharmacother; 1995 Mar; 29(3):257-9. PubMed ID: 7606070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis.
    Scully LJ; Clarke D; Barr RJ
    Dig Dis Sci; 1993 Apr; 38(4):744-51. PubMed ID: 8462374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol hepatotoxicity: report of a complicated case.
    Dumortier J; Guillaud O; Gouraud A; Pittau G; Vial T; Boillot O; Scoazec JY
    Ann Pharmacother; 2009 Oct; 43(10):1719-23. PubMed ID: 19776295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.